Published in Sex Transm Dis on January 09, 1991
The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun (2008) 1.97
Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun (2007) 1.85
Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun (2008) 1.77
Chlamydia trachomatis and ectopic pregnancy: retrospective analysis of salpingectomy specimens, endometrial biopsies, and cervical smears. J Clin Pathol (1995) 1.69
Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Infect Immun (2004) 1.60
Human antibody responses to a Chlamydia-secreted protease factor. Infect Immun (2004) 1.59
The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect Immun (2006) 1.47
A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum. J Immunol (2009) 1.39
Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infect Immun (2007) 1.37
Characterization of Chlamydia trachomatis plasmid-encoded open reading frames. J Bacteriol (2013) 1.31
Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen. J Bacteriol (2010) 1.18
Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner. BMC Microbiol (2008) 1.10
Reduced live organism recovery and lack of hydrosalpinx in mice infected with plasmid-free Chlamydia muridarum. Infect Immun (2013) 1.10
Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1. Microbiology (2011) 1.07
Oviduct infection and hydrosalpinx in DBA1/j mice is induced by intracervical but not intravaginal inoculation with Chlamydia muridarum. PLoS One (2013) 1.06
The chlamydial periplasmic stress response serine protease cHtrA is secreted into host cell cytosol. BMC Microbiol (2011) 1.04
Chlamydial induction of hydrosalpinx in 11 strains of mice reveals multiple host mechanisms for preventing upper genital tract pathology. PLoS One (2014) 1.04
Lack of long-lasting hydrosalpinx in A/J mice correlates with rapid but transient chlamydial ascension and neutrophil recruitment in the oviduct following intravaginal inoculation with Chlamydia muridarum. Infect Immun (2014) 1.01
Transformation of Chlamydia muridarum reveals a role for Pgp5 in suppression of plasmid-dependent gene expression. J Bacteriol (2013) 1.00
Transformation of sexually transmitted infection-causing serovars of chlamydia trachomatis using Blasticidin for selection. PLoS One (2013) 0.97
Mortality related to sexually transmitted diseases in US women, 1973 through 1992. Am J Public Health (1997) 0.96
Signaling via tumor necrosis factor receptor 1 but not Toll-like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection. Infect Immun (2014) 0.94
Chlamydia trachomatis secretion of an immunodominant hypothetical protein (CT795) into host cell cytoplasm. J Bacteriol (2011) 0.92
Induction of protective immunity against Chlamydia muridarum intracervical infection in DBA/1j mice. Vaccine (2013) 0.92
Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase. PLoS One (2012) 0.91
Enhanced upper genital tract pathologies by blocking Tim-3 and PD-L1 signaling pathways in mice intravaginally infected with Chlamydia muridarum. BMC Infect Dis (2011) 0.90
Localization of Chlamydia trachomatis hypothetical protein CT311 in host cell cytoplasm. Microb Pathog (2011) 0.90
A path forward for the chlamydial virulence factor CPAF. Microbes Infect (2013) 0.90
Complement factor C5 but not C3 contributes significantly to hydrosalpinx development in mice infected with Chlamydia muridarum. Infect Immun (2014) 0.89
The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women. Sex Transm Dis (2011) 0.89
Distinct roles of CD28- and CD40 ligand-mediated costimulation in the development of protective immunity and pathology during Chlamydia muridarum urogenital infection in mice. Infect Immun (2009) 0.89
Chlamydia trachomatis GlgA is secreted into host cell cytoplasm. PLoS One (2013) 0.88
Contribution of interleukin-12 p35 (IL-12p35) and IL-12p40 to protective immunity and pathology in mice infected with Chlamydia muridarum. Infect Immun (2013) 0.86
Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator. Microbes Infect (2013) 0.82
Immunodominant regions of a Chlamydia trachomatis type III secretion effector protein, Tarp. Clin Vaccine Immunol (2010) 0.82
Rottlerin inhibits chlamydial intracellular growth and blocks chlamydial acquisition of sphingolipids from host cells. Appl Environ Microbiol (2007) 0.82
Mortality from sexually transmitted diseases in reproductive-aged women: United States, 1999-2010. Am J Public Health (2014) 0.77
Chlamydial Lipoproteins Stimulate Toll-Like Receptors 1/2 Mediated Inflammatory Responses through MyD88-Dependent Pathway. Front Microbiol (2017) 0.75
Localization and characterization of GTP-binding protein CT703 in the Chlamydia trachomatis-Infected cells. Curr Microbiol (2010) 0.75
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91
A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med (1992) 10.70
Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol (1970) 10.68
Etiology of nongonococcal urethritis. N Engl J Med (1975) 9.61
New knowledge of chlamydiae and the diseases they cause. J Infect Dis (1975) 9.35
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA (1995) 7.31
Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. J Infect Dis (1972) 6.85
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 6.52
Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis (1974) 6.18
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis (1985) 5.29
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
Ovarian tumors in a cohort of infertile women. N Engl J Med (1994) 4.91
A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med (1996) 4.69
Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health (2001) 4.57
Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol (1999) 4.48
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy (1984) 4.39
Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med (1997) 4.21
Evaluation of smoking prohibition policy in a health maintenance organization. Am J Public Health (1986) 4.08
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity. Infect Immun (1978) 4.03
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis (1993) 4.02
BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med (1996) 3.83
Cellular basis of the immunological defects in thymectomized mice. Nature (1967) 3.69
Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test. Am J Ophthalmol (1967) 3.63
Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol (1982) 3.55
Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50
Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol (1982) 3.37
Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother (1977) 3.34
Chlamydia trachomatis as possible cause of peritonitis and perihepatitis in young women. Br Med J (1978) 3.33
Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int (2000) 3.29
Relation of high blood pressure to headache, epistaxis, and selected other symptoms. The United States Health Examination Survey of Adults. N Engl J Med (1972) 3.27
Environmental factors and the risk for childhood pedestrian-motor vehicle collision occurrence. Am J Epidemiol (1990) 3.21
Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest (1977) 3.18
Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis (1989) 3.15
Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis (1979) 3.12
Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11
Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol (1975) 3.03
Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02
Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00
Three new immunologic types of trachoma-inclusion conjunctivitis organisms. J Immunol (1973) 2.96
A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93
Correlation of circulating capsular polysaccharide with bacteremia in pneumococcal pneumonia. Infect Immun (1972) 2.93
History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 2.92
Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91
The role of poultry and meats in the etiology of Campylobacter jejuni/coli enteritis. Am J Public Health (1986) 2.90
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86
The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med (1984) 2.80
Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet (1991) 2.75
Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med (1987) 2.74
A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 2.74
Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst (2001) 2.73
Estimating the risk of breast cancer in relation to the interval since last term pregnancy. Epidemiology (1997) 2.72
Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc (1999) 2.71
Trachoma vaccine studies in monkeys. Am J Ophthalmol (1967) 2.65
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis (1985) 2.60
Epidemiology of childhood injuries. II. Sex differences in injury rates. Am J Dis Child (1982) 2.59
Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA (1970) 2.58
Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.58
Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55
Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology (1994) 2.51
Risk of breast cancer among young women: relationship to induced abortion. J Natl Cancer Inst (1994) 2.51
Epidemiology of Mycoplasma pneumoniae infection in families. JAMA (1966) 2.49